i n f l a r x

Loading

InflaRx Announces New Pipeline Program – Oral C5aR Inhibitor Home Investors Press Releases InflaRx Announces New Pipeline Program – Oral C5aR Inhibitor

Jan 10, 2022

Time to read 4 Minutes